Juvenile Idiopathic Arthritis
Conditions
Brief summary
The iPeer2Peer program matches teens with arthritis to an older mentor who has learned to manage their arthritis well and can support them emotionally and socially. This study will compare two groups of teens: those who are in the iPeer2Peer Program and those in the control group (no mentor).
Detailed description
Arthritis is a common childhood illness that makes everyday activities hard for young people. It is a long-lasting illness that can make you feel pain, tired and emotionally upset. This can make it hard for children and teens to see friends and do the activities that they like. The goal of this project is to find out if the newly developed peer mentoring program called iPeer2Peer helps teens with arthritis take better care of their illness and feel more connected to other people with arthritis. The iPeer2Peer program matches teens with arthritis to an older mentor who has learned to manage their arthritis well and can support them emotionally and socially. This study will compare two groups of teens: those who are in the iPeer2Peer Program and those in the control group (no mentor).
Interventions
BEHAVIORALiPeer2Peer Mentorship
10 sessions of 20-30 minute Skype calls conducted over 5-12 weeks.
The control group will receive standard care but without the iPeer2Peer program.
Sponsors
Provincial Health Services Authority British Columbia
IWK Health Centre
Children's Hospital of Eastern Ontario
The Hospital for Sick Children
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
12 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
* males and females 12-18 years old * rheumatologist-diagnosed JIA according to ILAR criteria * able to speak and read English * access to a computer, smartphone or tablet capable of using free Skype software (note: participants who do not have adequate Internet access will be provided with portable Internet sticks) * willing and able to complete online measures.
Exclusion criteria
* significant cognitive impairments * major co-morbid illnesses (medical or psychiatric conditions) likely to influence HRQL assessment * participating in other peer support or self-management interventions.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| TRANSITION-Q (measuring change) | Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post | 14-item measure of self-management skills that is both reliable (internally consistent, test-retest) and valid (face, construct and content validity) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| PROMIS Pain Interference (measuring change) | Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post | Pain |
| Screen for Child Anxiety Related Disorders (measuring change) | Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post | Emotional distress |
| Center for Epidemiologic Studies Depression Scale Revised (measuring change) | Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post | Emotional distress |
| Medical Issues, Exercise, Pain and Social Support Questionnaire (measuring change) | Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post | Disease knowledge |
| Children's Arthritis Self-Efficacy (measuring change) | Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post | Self-efficacy |
| PROMIS Pediatric Peer Relationship Scale (measuring change) | Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post | Perceived social support |
| PedsQL Arthritis Module (measuring change) | Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post | Health-related quality of life |
| Health service use and costs (measuring change) | Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post | Cost utility analysis |
| Mentor Behavior Scale (measuring change) | Post-Intervention (approximately following 12 weeks of calls) | Mentor quality |
| PROMIS Adult Profile (measuring change) | At beginning of study and at end of study (approximately 3 years later) | For mentors only: mentor physical and emotional symptoms |
| PROMIS Satisfaction with Social Roles and Activities (measuring change) | At beginning of study and at end of study (approximately 3 years later) | For mentors only: perceived social role satisfaction |
| Chronic Disease Self-Efficacy Scale (measuring change) | At beginning of study and at end of study (approximately 3 years later) | For mentors only: self-efficacy |
| Mentor interaction form | Following completion of each mentee's calls (approximately following 12 weeks of calls) | Record of interactions with mentees |
| AQoL-6D, interview (measuring change) | Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post | Cost utility analysis |
Countries
Canada
Outcome results
None listed